Authors:
S-E Glont, I Chernukhin, JS Carroll
Journal name: 
Cell Rep
Citation info: 
26(10):2558-2565.e3
Abstract: 
Considerable work has linked hormone receptors, such as estrogen receptor-alpha (ER), with the pioneer factor FOXA1. Altered FOXA1 levels contribute to endocrine-resistant breast cancer, where it maintains ER-chromatin interactions, even in contexts in which cells are refractory to ER-targeted drugs. A recent study controversially suggests that FOXA1 binding can be induced by hormonal pathways, including the estrogen-ER complex. We now show that the vast majority (>99%) of FOXA1 binding events are unaffected by steroid activation. A small number (<1%) of FOXA1 binding sites appear to be induced by estrogen, but these are created from chromatin interactions between ER binding sites and adjacent FOXA1 binding sites and do not represent genuine new FOXA1-pioneering elements. FOXA1 is therefore not regulated by estrogen and remains a bone fide pioneer factor that is entirely upstream of the ER complex.
DOI: 
http://doi.org/10.1016/j.celrep.2019.02.036
Research group: 
Carroll Group
E-pub date: 
28 Feb 2019
Users with this publication listed: 
Jason Carroll